Works matching DE "VERTEPORFIN"

Results: 88

Modulation of Intracellular Oxygen Pressure by Dual‐Drug Nanoparticles to Enhance Photodynamic Therapy.

Published in:

Advanced Functional Materials, 2019, v. 29, n. 10, p. N.PAG, doi. 10.1002/adfm.201806708

By:

Fan, Ya‐Tong;
Zhou, Tian‐Jiao;
Cui, Peng‐Fei;
He, Yu‐Jing;
Chang, Xin;
Xing, Lei;
Jiang, Hu‐Lin

Publication type:

Article

A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy.

Published in:

Turkish Journal of Medical Sciences, 2012, v. 42, n. 4, p. 681, doi. 10.3906/sag-1101-1470

By:

TOKLU, Yasin;
ÇAKMAK, Hasan Basri;
YORGUN, Mücella ARIKAN;
ERGUN, Şule Berk;
ŞİMŞEK, Şaban

Publication type:

Article

Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.

Published in:

European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 2, p. 278

By:

HUA, L.;
LIN, B.;
HONG, J.;
MIN, H.-B.;
HAN, W.-L.;
ZHOU, T.-Y.;
ZHANG, Z.-Q.

Publication type:

Article

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

Published in:

Oral Diseases, 2024, v. 30, n. 5, p. 3261, doi. 10.1111/odi.14775

By:

Yamashita, Junya;
Kimoto, Akira;
Teraoka, Shun;
Hiraoka, Yujiro;
Takeda, Daisuke;
Kakei, Yasumasa;
Shigeoka, Manabu;
Hasegawa, Takumi;
Akashi, Masaya

Publication type:

Article

Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.

Published in:

Frontiers in Physiology, 2016, p. 1, doi. 10.3389/fphys.2016.00400

By:

Jain, Manish;
Zellweger, Matthieu;
Frobert, Aurélien;
Valentin, Jérémy;
van den Bergh, Hubert;
Wagnières, Georges;
Cook, Stéphane;
Giraud, Marie-Noelle

Publication type:

Article

Subfoveal koroid neovaskülarizasyonlu yaşa bağlı maküla dejenerasyonunda fotodinamik tedavi uygulaması.

Published in:

Journal of Harran University Medical Faculty / Harran Üniversitesi Tıp Fakültesi Dergisi, 2018, v. 15, n. 3, p. 194

By:

ADIBELLİ, Fatih Mehmet;
HALPERT, Michael

Publication type:

Article

Proteostasis trumps YAP in colon cancer.

Published in:

Science Signaling, 2015, v. 8, n. 397, p. 1, doi. 10.1126/scisignal.aad3123

By:

Avril, Tony;
Chevet, Eric

Publication type:

Article

Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.

Published in:

Science Signaling, 2015, v. 8, n. 397, p. 1, doi. 10.1126/scisignal.aac5418

By:

Huabing Zhang;
Ramakrishnan, Sadeesh K.;
Triner, Daniel;
Centofanti, Brook;
Maitra, Dhiman;
Győrffy, Balázs;
Sebolt-Leopold, Judith S.;
Dame, Michael K.;
Varani, James;
Brenner, Dean E.;
Fearon, Eric R.;
Omary, M. Bishr;
Shah, Yatrik M.

Publication type:

Article

Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.

Published in:

European Journal of Oral Sciences, 2025, v. 133, n. 1, p. 1, doi. 10.1111/eos.13034

By:

Shan, Aung Phyo;
Hlaing, Khin Swe;
Leelahavanichkul, Asada;
Amornphimoltham, Panomwat

Publication type:

Article

Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 235, p. 1, doi. 10.1186/s13046-016-0414-z

By:

Hui Li;
Zhenglan Huang;
Miao Gao;
Ningshu Huang;
Zhenhong Luo;
Huawei Shen;
Xin Wang;
Teng Wang;
Jing Hu;
Wenli Feng

Publication type:

Article

Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.

Published in:

BioMed Research International, 2020, p. 1, doi. 10.1155/2020/3190136

By:

Iwase, Takehito;
Yokouchi, Hirotaka;
Kitahashi, Masayasu;
Kubota-Taniai, Mariko;
Baba, Takayuki;
Yamamoto, Shuichi

Publication type:

Article

Photodynamic Therapy with Verteporfin for Choroidal Metastasis Refractory to Radiotherapy.

Published in:

Case Reports in Oncology, 2019, v. 12, n. 3, p. 861, doi. 10.1159/000502226

By:

Zhou, Raymond;
Reichstein, David

Publication type:

Article

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Published in:

Clinical Ophthalmology, 2018, v. 12, p. 1789, doi. 10.2147/OPTH.S171015

By:

Takahashi, Kanji;
Ohji, Masahito;
Terasaki, Hiroko;
Honda, Shigeru;
Margaron, Philippe;
Guerin, Tadhg;
Yuzawa, Mitsuko

Publication type:

Article

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 2145, doi. 10.2147/OPTH.S151933

By:

Dhirani, Nadeem Ali;
Yelin Yang;
Somani, Sohel

Publication type:

Article

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 223, doi. 10.2147/OPTH.S119510

By:

Gallemore, Ron P.;
Wallsh, Josh;
Hudson, Henry L.;
Ho, Allen C.;
Chace, Richard;
Pearlman, Joel

Publication type:

Article

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation.

Published in:

Clinical Ophthalmology, 2016, v. 10, p. 861, doi. 10.2147/OPTH.S106092

By:

Arias, Luis;
Gómez-Ulla, Francisco;
Ruiz-Moreno, José M.

Publication type:

Article

Current and emerging treatment options for myopic choroidal neovascularization.

Published in:

Clinical Ophthalmology, 2015, v. 9, p. 733, doi. 10.2147/OPTH.S49437

By:

El Matri, Leila;
Chebil, Ahmed;
Kort, Fedra

Publication type:

Article

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Published in:

Clinical Ophthalmology, 2014, v. 8, p. 685, doi. 10.2147/OPTH.S58617

By:

Alkin, Zeynep;
Perente, Irfan;
Ozkaya, Abdullah;
Alp, Dilek;
Agca, Alper;
Demet Aygit, Ebru;
Korkmaz, Selcuk;
Taylan Yazici, Ahmet;
Demirok, Ahmet

Publication type:

Article

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin.

Published in:

2013

By:

Setsuko Kawakami;
Yoshihiro Wakabayashi;
Hiroshi Goto

Publication type:

Case Study

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 1867, doi. 10.2147/OPTH.S32177

By:

Karim, Shaheen P.;
Adelman, Ron A.

Publication type:

Article

Five-year results of photodynamic therapy with verteporin for Japanese patients with neovascular age-related macular degeneration.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 615, doi. 10.2147/OPTH.S43566

By:

Tsuchihashi, Takashi;
Mori, Keisuke;
Ueyama, Kazuhiro;
Yoneya, Shin

Publication type:

Article

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 87, doi. 10.2147/OPTH.S39584

By:

Ratanasukon, Mansing;
Thongthong, Koblarp;
Bhurayanontachai, Patama;
Jirarattanasopa, Pichai

Publication type:

Article

Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy.

Published in:

Journal of Ophthalmology, 2020, p. 1, doi. 10.1155/2020/8491712

By:

Stattin, Martin;
Hagen, Stefan;
Ahmed, Daniel;
Smretschnig, Eva;
Frommlet, Florian;
Krepler, Katharina;
Ansari-Shahrezaei, Siamak

Publication type:

Article

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

Published in:

British Journal of Cancer, 2014, v. 110, n. 7, p. 1698, doi. 10.1038/bjc.2014.95

By:

Huggett, M T;
Jermyn, M;
Gillams, A;
Illing, R;
Mosse, S;
Novelli, M;
Kent, E;
Bown, S G;
Hasan, T;
Pogue, B W;
Pereira, S P

Publication type:

Article

Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment through Hippo-YAP Signaling In Vitro and In Vivo.

Published in:

BioMed Research International, 2022, p. 1, doi. 10.1155/2022/3215461

By:

Yao, Wangxiang;
Ma, An;
Zhang, Zhen;
Zhu, Liulong

Publication type:

Article

Combined intravitreal ranibizumab and verteporfin photodynamic therapy versus ranibizumab alone for the treatment of age-related macular degeneration.

Published in:

Digital Journal of Ophthalmology, 2011, v. 17, p. 23, doi. 10.5693/djo.01.2011.05.003

By:

Giustolisi, Rosalia;
Fantozzi, Nicoletta;
Staltari, Mariateresa;
Marchiori, Jessica;
Mastrangelo, Olga;
Marcucci, Roberta;
Mirra, Federica;
Mazzotta, Paola;
Gabrieli, Corrado Balacco

Publication type:

Article

Intestinal Epithelial Cell-Intrinsic Deletion of Setd7 Identifies Role for Developmental Pathways in Immunity to Helminth Infection.

Published in:

PLoS Pathogens, 2016, v. 12, n. 9, p. 1, doi. 10.1371/journal.ppat.1005876

By:

Oudhoff, Menno J.;
Antignano, Frann;
Chenery, Alistair L.;
Burrows, Kyle;
Redpath, Stephen A.;
Braam, Mitchell J.;
Perona-Wright, Georgia;
Zaph, Colby

Publication type:

Article

Research progress of hydroxychloroquine and autophagy inhibitors on cancer.

Published in:

2017

By:

Shi, Ting-Ting;
Yu, Xiao-Xu;
Yan, Li-Jun;
Xiao, Hong-Tao

Publication type:

journal article

Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2016, v. 39, n. 2, p. 481, doi. 10.1159/000445640

By:

Pan, Wang;
Wang, Qian;
Zhang, Yi;
Zhang, Naishu;
Qin, Jiamin;
Li, Wei;
Wang, Jing;
Wu, Fangfang;
Cao, Lingsen;
Xu, Guanglin

Publication type:

Article

Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.

Published in:

Eye, 2013, v. 27, n. 5, p. 612, doi. 10.1038/eye.2013.24

By:

Karakus, S H;
Basarir, B;
Pinarci, E Y;
Kirandi, E U;
Demirok, A

Publication type:

Article

Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study.

Published in:

Ophthalmologica, 2015, v. 233, n. 2, p. 66, doi. 10.1159/000367603

By:

Hatz, Katja;
Schneider, Ulrike;
Henrich, P. Bernhard;
Braun, Beatrice;
Sacu, Stefan;
Prünte, Christian

Publication type:

Article

Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice.

Published in:

Ophthalmologica, 2013, v. 230, n. 1, p. 34, doi. 10.1159/000350802

By:

Studnička, Jan;
Říhová, Barbora;
Rencová, Eva;
Rozsíval, Pavel;
Dubská, Zora;
Chrapek, Oldřich;
Kolář, Petr;
Kandrnal, Vít;
Demlová, Regina;
Pitrová, Šárka;
Řehák, Jiří

Publication type:

Article

Photodynamic Therapy Combined with Intravitreal Bevacizumab (Avastin) in Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.

Published in:

Collegium Antropologicum, 2007, v. 31, n. s1, p. 71

By:

Lazić, Ratimir;
Gabrić, Nikica;
Dekaris, Iva;
Gavrić, Morena;
Bosnar, Damir

Publication type:

Article

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas.

Published in:

Cancers, 2021, v. 13, n. 4, p. 675, doi. 10.3390/cancers13040675

By:

Rytlewski, Jeffrey D.;
Scalora, Nicholas;
Garcia, Keith;
Tanas, Munir;
Toor, Fatima;
Miller, Benjamin;
Allen, Bryan;
Milhem, Mohammed;
Monga, Varun;
van Houdt, Winan J.;
Kasper, Bernd;
Beier, Justus P.

Publication type:

Article

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth.

Published in:

Cancers, 2020, v. 12, n. 12, p. 3847, doi. 10.3390/cancers12123847

By:

Morice, Sarah;
Mullard, Mathilde;
Brion, Regis;
Dupuy, Maryne;
Renault, Sarah;
Tesfaye, Robel;
Brounais-Le Royer, Bénédicte;
Ory, Benjamin;
Redini, Françoise;
Verrecchia, Franck

Publication type:

Article

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing.

Published in:

Cancers, 2020, v. 12, n. 9, p. 2717, doi. 10.3390/cancers12092717

By:

Zawacka-Pankau, Joanna E.

Publication type:

Article

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.

Published in:

Cancers, 2020, v. 12, n. 4, p. 778, doi. 10.3390/cancers12040778

By:

García, Patricia;
Rosa, Lorena;
Vargas, Sergio;
Weber, Helga;
Espinoza, Jaime A.;
Suárez, Felipe;
Romero-Calvo, Isabel;
Elgueta, Nicole;
Rivera, Vanessa;
Nervi, Bruno;
Obreque, Javiera;
Leal, Pamela;
Viñuela, Eduardo;
Aguayo, Gloria;
Muñiz, Sabrina;
Sagredo, Alfredo;
Roa, Juan C.;
Bizama, Carolina

Publication type:

Article

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo.

Published in:

Cancers, 2019, v. 11, n. 11, p. 1760, doi. 10.3390/cancers11111760

By:

Michy, Thierry;
Massias, Thibault;
Bernard, Claire;
Vanwonterghem, Laetitia;
Henry, Maxime;
Guidetti, Mélanie;
Royal, Guy;
Coll, Jean-Luc;
Texier, Isabelle;
Josserand, Véronique;
Hurbin, Amandine

Publication type:

Article

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus.

Published in:

International Medical Case Reports Journal, 2017, v. 10, p. 51, doi. 10.2147/IMCRJ.S107648

By:

Wong, James G.;
Xin Jie Lai;
Sarafian, Richard Y.;
Hon Seng Wong;
Smith, Jeremy B.

Publication type:

Article

Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 12, p. 2363, doi. 10.1007/s00417-017-3805-8

By:

Kim, Jonathan;
Jacobsen, Bradley;
Zolfaghari, Emily;
Ferrario, Angela;
Chevez-Barrios, Patricia;
Berry, Jesse;
Lee, Diana;
Rico, Grecia;
Madi, Ingy;
Rao, Narsing;
Stachelek, Kevin;
Wang, Lei-chi;
Gomer, Charles

Publication type:

Article

One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 541, doi. 10.1007/s00417-016-3500-1

By:

Matsumiya, Wataru;
Honda, Shigeru;
Otsuka, Keiko;
Miki, Akiko;
Nagai, Takayuki;
Imai, Hisanori;
Kusuhara, Sentaro;
Nakamura, Makoto

Publication type:

Article

Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 529, doi. 10.1007/s00417-016-3498-4

By:

Rinaldi, M.;
Semeraro, F.;
Chiosi, F.;
Russo, A.;
Romano, M.;
Savastano, M.;
dell'Omo, R.;
Costagliola, C.

Publication type:

Article

The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2013, v. 251, n. 4, p. 1081, doi. 10.1007/s00417-012-2139-9

By:

Hagen, Stefan;
Ansari-Shahrezaei, Siamak;
Smretschnig, Eva;
Glittenberg, Carl;
Krebs, Ilse;
Graf, Alexandra;
Binder, Susanne

Publication type:

Article

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Published in:

2013

By:

Mak, Shiu;
Wong, Albert

Publication type:

Letter

Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy.

Published in:

2013

By:

Arevalo, J.;
Espinoza, Juan

Publication type:

Letter

Photodynamic Therapy for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome.

Published in:

2014

By:

Monteiro, Sílvia;
Casal, Inês;
Santos, Marinho;
Meireles, Angelina

Publication type:

Case Study

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup.

Published in:

Case Reports in Medicine, 2012, p. 1, doi. 10.1155/2012/897097

By:

Fernández, Maribel;
Gil, María;
Gomez-Ulla, Francisco;
Charlón, Pablo

Publication type:

Article

Current management strategy of polypoidal choroidal vasculopathy.

Published in:

2018

By:

Ho, Christine;
Lai, Timothy;
Ho, Christine P S;
Lai, Timothy Y Y

Publication type:

journal article

Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.

Published in:

2018

By:

Kumar, Atul;
Mutha, Vineet;
Sundar, Dheepak M.

Publication type:

journal article

Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.

Published in:

2018

By:

Jain, Prashant;
Anantharaman, Giridhar;
Gopalakrishnan, Mahesh;
Goyal, Anubhav

Publication type:

journal article